Poolbeg Pharma PLC (POLB.L)
GBp 3.05
(-6.15%)
GBp 3.05
(-6.15%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -4.66 Million GBP | 6.05% |
| 2022 | -4.96 Million GBP | -113.98% |
| 2021 | -2.31 Million GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1258.00 GBP | 0.0% |
| 2024 Q1 | -1258.00 GBP | 99.95% |
| 2023 Q3 | -1295.00 GBP | 99.94% |
| 2023 FY | - GBP | -1.13% |
| 2023 Q1 | -1035.00 GBP | 99.97% |
| 2023 Q2 | -2.24 Million GBP | -217001.45% |
| 2023 Q4 | -2.78 Million GBP | -214571.81% |
| 2022 Q2 | -1.87 Million GBP | -215196.15% |
| 2022 FY | - GBP | -113.98% |
| 2022 Q4 | -3.36 Million GBP | -192297.83% |
| 2022 Q3 | -1749.50 GBP | 99.91% |
| 2022 Q1 | -869.50 GBP | 0.0% |
| 2021 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|